Dow Chemical is an AWE facility from 1957-2007 so workers are eligible to file Part B claims.
Dow has a Special Exposure Cohort for all workers with specific cancers and who were employed at least 250 days between January 1, 1957-December 31, 1960.
The Dow facility in Madison, Illinois, supplied the AEC with Magnesium-thorium sheets and plates, non radioactive equipment, metal products and other services. Dow received a purchase order from Mallinckrodt in March 1960, for research and development on the extrusion of uranium metal and rod. The Department of Energy also has invoices from 1957 and 1958 indicating that the Mallinckrodt Chemical Company Uranium division purchased magnesium-thorium plates and sheets from the Dow Chemical Company in Madison Illinois.
Dow sold this facility in 1969 to Consolidated Aluminum, which continued to operate the facility from 1969 through 1986. However, during the period of 1969-1986, the operations were of a purely commercial nature and did not involve AEC or Department of Energy contracts. Spectrulite subsequently purchased the plant from Consolidated Aluminum.
Although this site was designated as part of the Formerly Utilized Site Remediation Action Program (FUSRAP) in 1992, no remediation work ever took place under the DOE FUSRAP program prior to that program being transferred to the Army Corps of Engineers in 1997.
During the period of residual contamination, as designated by the National Institute for Occupational Safety and Health and as noted in the dates above, employees of subsequent owners and operators of this facility are also covered under the Energy Employees Occupational Illness Compensation Program Act.
DOE's Legacy Management has a webpage for Dow Chemical.
DOL provides Part B statistics on Dow Chemical.
NIOSH also provided dose reconstruction statistics for Dow Chemical.